Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Endocrine 1CNS 1

Conditions

Pituitary Neoplasms 1Optic Nerve Glioma 1Oligodendroglioma 1Neuroectodermal Tumors, Primitive 1Neoplasms, Germ Cell and Embryonal 1Meningioma 1Medulloblastoma 1Glioma, Subependymal 1Glioma 1Glioblastoma 1Germinoma 1Ependymoma 1Craniopharyngioma 1Chordoma 1Brain Neoplasms 1Astrocytoma 1

Interventions

entinostat 1Vorinostat 1Temozolomide 1Tamoxifen 1Surveys and Questionnaires 1Radiotherapy 1Photochemotherapy 1Fentanyl 1Doxorubicin 1Dihematoporphyrin Ether 1Dexamethasone 1Cisplatin 1Calcium Dobesilate 190Y-octreotide, DOTA-Tyr(3)- 12,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Oligodendroglioma × Dihematoporphyrin Ether × Endocrine × Clear all
NCT01682746 2019-02-25

Photodynamic Therapy (PDT) for Recurrent Pediatric Brain Tumors

Medical College of Wisconsin

Phase 1 Completed
5 enrolled
CNSEndocrineSarcoma

Astrocytoma, Brain Neoplasms, Chordoma, Craniopharyngioma, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Neoplasms, Germ Cell and Embryonal, Oligodendroglioma, Pituitary Neoplasms, Germinoma, Neuroectodermal Tumors, Primitive, Glioma, Subependymal, Optic Nerve Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡